Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13.8). Average mean blood pressure while on aggressive therapy with conventional medication was 144 ± 14 mm Hg; on minoxidil and propranolol it was 108 10 mm Hg (P < 2.5 X 10-6, paired t-test). Sodium retention was a frequently observed limiting factor to optimum blood pressure control and required large doses of furosemide to control. Propranolol blunted the reflex tachycardia associated with arteriolar dilator therapy but all patients continued with a clinically hyperdynamic circulation. Seven of seven had elevated ejection fractions on echocardiogram, and two of three had elevated cardiac indices. Three of three who had heart catheterization had pulmonary hypertension which was aggravated by exercise. An additional three patients on hydralazine, propranolol, and furosemide also had pulmonary hypertension suggesting this is not unique to minoxidil. Two of thirteen developed pericardial effusions. Renal function improved in three and worsened in three.
M INOXIDIL, a piperidino-pyrimadine derivative (Upjohn U-10,858), is an orally effective vasodilator acting directly on vascular smooth muscle. This effect appears to be most pronounced at the arteriolar level thereby reducing peripheral vascular resistance without significant sympatholysis or increase in venous capacitance. Peak plasma levels occur within 1 hour following an oral dose. The serum half life is approximately 41/2 hours but its duration of action may be up to 24 hours, apparently because of binding of the active drug in vascular wall. [1] [2] [3] [4] Gilmore et al. initially demonstrated, in short-term studies, the effectiveness of minoxidil in combination with propranolol (Inderal) for the control of hypertension in hospitalized subjects.5 Limas and Fries reported the effective use of minoxidil, in combination with conventional antihypertensive medications, in treating uncontrollable hypertension in uremics on chronic hemodialysis.`Gottleib et al. in a non-blinded study claimed superiority of minoxidil over hydralazine (Apresoline), both used in conjunction with propranolol and diuretics.7 Pettinger and Mitchell have suggested minoxidil and propranolol may be an alternative to nephrectomy in the treatment of refractory hypertension. 8 We herein report our own successful experience with minoxidil, used in combination with propranolol and a diuretic, for the long-term treatment of a highly selected group of outpatients with severe hypertension uncontrolled by vigorous treatment with conventional antihypertensive medications. The study is nonblinded, and each patient serves as his own control only in a sequential manner. Although all patients were refractory to conventional medications at the time of institution of minoxidil, the protocol does not justify definite conclusions regarding relative effectiveness of conventional medication vs minoxidilpropranolol therapy. The purposes of this study are to confirm previously reported effectiveness of shortterm therapy with minoxidil and to extend this to an evaluation of chronic outpatient therapy.
Material and Methods

Patients
The study group is comprised of 13 patients who have remained on minoxidil therapy in combination with propranolol and furosemide (9) or periodic hemodialysis (4) for nine months or longer. Criteria for institution of minoxidil was poorly controlled hypertension defined as supine diastolic blood pressure (BP) greater than 105 mm Hg and systolic BP greater than 160 mm Hg while on large doses of conventional antihypertensive medication (table 1) . Four of 13 patients had standing diastolic BP less than 105 mm Hg but had disabling side effects of therapy or rapidly worsening renal function associated with sodium depletion. There were eight males and five females, seven black and six white, seven to fifty-six years of age.
Methods
All patients initially had complete history and physical examination and appropriate laboratory evaluation, inCirculation, Volume 52, October 1975 fig. 1 ). Most patients had troublesome to disabling side effects of therapy, and nearly all patients were sufficiently symptomatic from these or hypertensive complications to preclude regular employment.
Minoxidil
The patients have remained on minoxidil, propranolol, and furosemide (eleven) or hemodialysis (two) with duration of therapy from nine to twenty-five months (mean 13.8). Nine of thirteen remain on minoxidil as of October 1974. In two cases (6 and 15) minoxidil was electively discontinued after eighteen Headache was infrequently noted in the first several days of minoxidil therapy. This always responded within hours to increased propranolol. Hirsuitism was always noted and was controlled with dipilatories or shaving. With these exceptions, side effects were notably absent, and patient acceptance was excellent. All patients are followed as outpatients and none remain medically disabled from hypertension.
Twenty-four PRA assays, taken at random from ten patients while on therapy, ranged from 1.2 to 57 ng/ml/hr. Only six of twenty-four such determinations were under 5 ng/ml/hr despite the high doses of propranolol. Neither hematologic nor hepatic toxicities were detected. No positive antinuclear antibodies were encountered. No clinical evidence of cerebrovascular insufficiency was apparent. Two patients (11 and 17) on chronic maintenance hemodialysis at start of therapy remain on dialysis. Two cases (3 and 15) who were on acute dialysis at the start of therapy have recovered sufficient renal function to discontinue dialysis. Case 3 now has a serum creatinine of 1 Figure 2 Serum creatinine at time of institution of minoxidil is shown at t = 0, and most recent creatinine at t = total duration of minoxidil therapy for each patient. The two patients who started and remain on dialysis were chronic dialysis patients while the two who started on dialysis but recovered were acute renal failure and both had hemolytic uremic syndrome. Abbreviations: H = hydralazine; P = propranolol; F = furosemide.
remained normal both at rest and with exercise in the third patient.
Discussion
Hydralazine and minoxidil, while chemically dissimilar, both dilate systemic arterioles, evoke reflex sympathetic activity and tend to be associated with sodium retention. Eight of our patients were taking hydralazine 100 mg every six hours in combination with propranolol in sufficient dose to keep resting pulse rate less than 75 per minute, and diuretics sufficient to maintain clinically normal ECV. None had sustained diastolic BP less than 110 mm Hg. The substitution of minoxidil for hydralazine, along with continued propranolol and furosemide was effective in lowering BP. While this study was not designed to compare hydralazine and minoxidil, it would appear that in severe hypertension minoxidil may be more effective. Controlled, double-blind studies to test this are presently underway.
The physiology of antihypertensive therapy with vasodilators has been recently reviewed. "1 The primary abnormality of most chronic essential hypertensive patients is an abnormal elevation of peripheral vascular resistance. Arteriolar dilators act directly to reverse this abnormality, but used alone their effectiveness in lowering blood pressure is limited by at least three factors. There is a reflex elevation of sympathetic activity due to stimulation of baroreceptors by the reduced arterial pressure as well as perhaps direct central nervous system stimulation by high levels of angiotensin.12 Secondly, there is increased peripheral renin activity.5' 1' This increase in renin activity may be suppressed by beta-adrenergic blockers and appears to be caused in part by heightened adrenergic state rather than by renal artery hypotension per se.'3' 14 Thirdly, there is sodium retention and expansion of ECV. The net result of heightened sympathetic activity and sodium retention is an increase in cardiac output, thereby limiting the hypotensive effect of arteriolar dilators.
Circulation, Volume 52, October 1975 Beta-adrenergic blockade with propranolol may decrease the reflex increase in sympathetic activity5 as well as the rise in renin activity. Diuretics may offset the sodium retention. The combined use of minoxidil, propranolol and diuretic has been reported to be highly effective in controlling severe hypertension for relatively short periods of time. Our experience allows us to examine the long-term use of this form of therapy not only with regard to BP control but of equal importance to assess potential long-term toxicity, cardiovascular and renal consequences. As in other studies, we found minoxidil to be highly effective in controlling BP and have extended this observation to as long as twenty-five months. In many cases the conversion from conventional antihypertensive therapy to minoxidil could be accomplished without hospitalization. In seven of thirteen cases, initial BP control was established within twenty-four hours and was therefore useful in acute hypertensive emergencies.
Because of the increasingly large doses of propranolol required to suppress the apparent hyperdynamic circulatory state, careful assessment of cardiopulmonary consequences was performed using echocardiograms and right heart catheterization. Serial noninvasive evaluation of left ventricular function was performed by echocardiography. The number of patients is small and the results must be considered as preliminary only. Furthermore, indirect echocardiographic assessment of left ventricular function must be confirmed by direct measurement. However, despite the large doses of propranolol, the seven patients so studied had hypertrophied, nondilated left ventricles with marked hyperkinesis. Furthermore, two of three who had right heart catheterization had elevated cardiac index at rest and ability to further increase cardiac index with exercise. It appears that the large doses of propranolol, while suppressing heart rate, were not effective in suppressing hyperkinetic ventricular function. The possible consequences of such marked hyperkinesis in ad-dition to its established role in sustaining systemic hypertension remain unknown.
The finding of pulmonary hypertension in all three patients studied by catheterization is of special con The observation of peripheral edema formation in the absence of jugular venous distension, hepatojugular reflex, clinical or radiographic evidence of pulmonary venous congestion is of interest. Renal sodium retention is known to occur as a consequence of arteriolar dilator therapy. This may be a consequence of increased aldosterone and perhaps in part due to a primary action of minoxidil on renal sodium excretion. 4 There is evidence to suggest minoxidil, hydralazine, diazoxide and guancydine all increase proximal sodium reabsorption,'7 perhaps in part because of redistribution of renal blood flow. 18 Furthermore, the absence of rigid dietary sodium restriction along with large doses of propranolol in patients with histories of congestive heart failure might be suspected to have led to low output heart failure and subsequent sodium retention. No evidence of depressed myocardial function was observed, however, and in some cases who had previously been given digitalis for control of congestive heart failure, the cardiac glycosides were discontinued in an effort to suppress the observed myocardial hyperkinesis. The Treatment with arteriolar dilators may result in myocardial ischemia,5 7especially in patients with occlusive coronary artery disease. A few patients with severe left ventricular hypertrophy may develop clinical angina pectoris with angiographically patent coronary arteries apparently because of a relative coronary insufficiency to the greatly hypertrophied myocardium. There is a potential for ischemic myocardial damage in these patients as well. Betaadrenergic blockade will suppress the reflex tachyeardia5 7 and may reduce the risk of myocardial ischemia. It has been claimed that the incidence and severity of myocardial necrosis associated with acute reduction of BP by minoxidil, diazoxide, or hydralazine may be reduced by concurrent treatment with propranolol. '9 Of interest is reported evidence that minoxidil, both with and without propranolol, increases myocardial blood flow at all depths of the myocardium in dogs. 18 None of the patients in this series had angina pectoris prior to treatment nor developed angina on minoxidil. We have subsequently treated several patients with angina pectoris, left ventricular hypertrophy and angiographically patent coronary arteries with minoxidil while keeping pulse rate below 70 per minute with propranolol. None of these patients have had worsening of their angina pectoris, and in fact, subjectively have increased their pain-free exercise tolerance as BP decreased. However, the safety of treating patients with angina pectoris and severe hypertension with minoxidil and propranolol remains unproven. Further carefully controlled clinical trials must be carried out before it can be recommended.
Summary and Conclusions
The combination of minoxidil, propranolol and furosemide appears to be highly effective in controlling severe hypertension for up to twenty-five months. The oral route of administration and long Circulation, Volume 52, October 1975 duration of action make minoxidil well suited to outpatient use. Side effects, with the exception of hirsuitism, were notably absent, and patient acceptance was excellent. The patient's sense of well-being was good and rehabilitation potential excellent. No longterm toxic effects of therapy were detected. Severe sodium retention requiring large doses of furosemide to avoid increasing body weight and edema was a frequently observed factor associated with tolerance to the hypotensive effect of arteriolar dilatation. Despite the frequent occurrence of edema, no cases of clinical or radiographic pulmonary venous congestion occurred. With sustained control of BP and avoidance of excessive ECV depletion, renal function improved in three, worsened in three, and remained stable in seven. Propranolol was effective in blunting the sympathetic response to arteriolar dilators although all patients maintained a clinically hyperdynamic circulation with high pulse pressure. Seven of seven had elevated ejection fraction as determined by echocardiography, and two of three had elevated cardiac index determined with heart catheterization. Pulmonary hypertension was found in all three patients who had heart catheterization, and two of thirteen developed pericardial effusions. The causal relationship of the pulmonary hypertension or pericardial effusions to therapy remains unproven.
